Ghaith Aljayyoussi

Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial

Menno R. Smit, Eric Ochomo, Ghaith Aljayyoussi et al. · The Lancet Infectious Diseases · 2018 · 146 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +15

Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study

Hannah Slater, Brian D. Foy, Kevin C. Kobylinski et al. · The Lancet Infectious Diseases · 2020 · 94 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +14

Preclinical development of an oral anti- <i>Wolbachia</i> macrolide drug for the treatment of lymphatic filariasis and onchocerciasis

Mark J. Taylor, Thomas W von Geldern, Louise Ford et al. · Science Translational Medicine · 2019 · 85 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 Diagnosis

Rachel L. Byrne, Grant A. Kay, Konstantina Kontogianni et al. · Emerging infectious diseases · 2020 · 83 citations · Full text

Medicine, Infectious Diseases, Molecular Diagnostics +12

Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis

Ghaith Aljayyoussi, Hayley E. Tyrer, Louise Ford et al. · Scientific Reports · 2017 · 78 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17